CCTV 13 com CC E IN u CGTV 13) ccTV 20m 新 f 9 CCTV13 CCTM 20m s 4 1 (B 合肥滨湖科学城管委会副主任、安徽创新馆服务管理中心主任陈林称："因为有的技术需求虽然是实在的，可能特征不是很完整或者很有 效。梳理过程中间，围绕安徽的六大未来产业、十大新兴产业和16个地市的区域产业的特征，推动一些项目针对性地落地。" 为了能让他们的判断更有依据，当地刚刚上线了一个大模型。不仅可以评估一款未上市的专利价值，还能帮助专利所有者分析市场前景和 方向。 而没有入选的专利，也可以看到自己是在哪个维度出现了弱项，如果不是技术方向的问题，还可以有针对性地进行调整和改进。 基于可信的数据，分析出的结果也更受市场认可，科研团队甚至可以拿着评估报告到银行贷款，企业也知道专利的大致定价，后续转化过 程都会更加顺畅。 安徽：知识产权注入企业 赋权改革激活成果转化 在科技创新领域，基础研究如同"栽树"。如何让需要"十年磨一剑"培育的"科技种子"长成产业"参天大树"？安徽设立首期50亿元引导基 金，制定48项"激励+松绑+免责"措施，投资损失容忍率最高可达80%。同时，基本形成了 ...

2025年5月28日-30日 · 上海 2025年资本市场论坛 资本市场论坛是中信证券的半年度策略会,是每年规模 最大、规格最高、客户最多、影响力最广的年度大会之一。 历届年会参会人员均在四千人以上,主要包括百余位发言 嘉宾,中信证券境内外研究员,1000余家备受市场关注的 上市公司,重要的公私募基金、保险、银行、QFII和海外投 资者以及其他市场参与主体等,是专业的投资交流平台,也 是经济和金融领域的盛会。 2025年,全球经济在多重变局中探索发展路径。大国博弈 持续深化,外部经贸扰动明显加剧,产业链面临深度重构。特 朗普政府以"对等关税"为名,持续加码贸易壁垒,加剧市 场动荡。在复杂外部环境下,一季度中国经济开局良好,高 质量发展的根基持续夯实。 尊敬的客户: 您好! 中信证券2025年资本市场论坛定于2025年5月28日至5月 30日在上海举办，诚邀您的光临。 面对外部冲击影响加大,4月政治局会议强调强化底线思 维,充分备足预案。美关税政策仍可能因自身压力不断反复, 在此背景下,提升经济韧性、保护市场主体、团结国际力量 尤为重要。展望后续,财政政策将持续发力,专项债发行有 望进一步提速。货币政策延续适度 ...

Core Insights - The launch of the Shenzhen-Hong Kong cross-border data security and convenience channel aims to enhance data transmission safety and efficiency between the two regions [1][2] - The establishment of the Qianhai Data Industry Fund, with a total scale of 500 million yuan, is intended to foster a leading data industry cluster in China [2] Group 1: Cross-Border Data Channel - The Shenzhen-Hong Kong cross-border data security channel is guided by the Shenzhen Municipal Cyberspace Administration and relies on the National (Shenzhen·Qianhai) New Internet Exchange Center [1] - The channel will implement a "three-in-one" framework, including a dedicated security channel, a cross-border data inspection station, and a comprehensive service center [1] - The initial application of the channel will focus on the healthcare sector, facilitating cross-border medical services for residents in the Greater Bay Area [1] Group 2: Data Industry Fund - The Qianhai Data Industry Fund is co-funded by the Qianhai Management Bureau and the Baoan District Government Data Bureau, with a total scale of 500 million yuan [2] - The fund will primarily invest in data resources, technology, services, applications, security, and infrastructure, aiming to cultivate high-growth data technology enterprises [2] - The Qianhai Management Bureau plans to establish a robust mechanism for efficient and secure cross-border data flow to support international data circulation [2]

Core Viewpoint - The incident has evolved from a personal and family crisis into a broader trust crisis affecting the medical and educational systems, highlighting concerns over integrity and public interest [1][2][3] Group 1: Incident Overview - The initial issue involved a doctor at a hospital being reported for personal misconduct, leading to his expulsion from the party and termination of employment [1] - As more details emerged, a female resident physician became the focus, raising questions about her rapid advancement in the medical field, which appeared to involve potential privilege and irregularities [1][2] Group 2: Public Concerns - Public skepticism centers on three main areas: the legitimacy of the female physician's educational and professional journey, the potential misuse of the "4+4" training model at Peking Union Medical College, and the overall compliance of medical schools in their admissions and training processes [2][3] - There is a growing demand for accountability and transparency from relevant institutions, as the public seeks clarity on whether any violations occurred and how they will be addressed [2][3] Group 3: Institutional Response - The lack of timely responses from regulatory bodies has led to increased public scrutiny, with concerns that deleting unfavorable information only exacerbates doubts about the integrity of the involved institutions [2][3] - It is crucial for the institutions to acknowledge the severity of the situation, investigate the facts, and either rectify any issues or clear the names of those wrongfully accused to restore public trust [3]

由上海市总工会、东方娱乐、SMG纪录片创制中心（真实传媒）联合打造的《上海工匠第十季——奋楫》将于5月1日至5日每天8:05在东方卫视两集连播。 节目海报 值此上海市总工会百年华诞之际，节目以"百舸争流，奋楫者先"的进取精神为核，聚焦临床医学、智慧港口、精密测量、海洋工程等领域的十位上海顶尖工 匠。 张蕾 这位非科班出身的"网络尖兵"，在看不见的维度演绎着攻防战。两会、进博会、党的二十大，她在数字洪流中筑坝，用渗透测试撕裂防御假象，以漏洞挖掘 构筑坚实护盾。五年间，她在虚拟战场淬炼出的不仅是技术利刃，更是守护光明的信念——每个补丁都在书写"此路不通"的宣言。 上海工业自动化仪表研究院有限公司张怀锁，正用中国力值重新定义世界测量体系。 在坚冰上镌刻中国精度 在灯火通明的城市背后，在洋山港的万吨巨轮旁，在新能源海域的长风波涛里，有这样一群以匠心为舟、以勇毅作楫的孤勇者，用毫厘必争的精度刻下中国 智造的高度。 张怀锁 面对钢铁、建筑、交通、航空航天等领域的"万吨级"力值检测空白，他带领团队用五年光阴浇筑出世界首台套100MN力标准测力机，在极限载荷下验证 了"中国芯"的硬核实力。其主导研发的最大量程70MN轧制力传 ...

Core Viewpoint - The article discusses the evolution of elderly care from basic support to a more integrated approach that combines medical care and elderly services, addressing the pressing healthcare needs of the aging population [1]. Group 1: Medical and Elderly Care Integration - The establishment of "medical and elderly care integration" is exemplified by the proximity of TaiKang ZhiJia SuYuan and TaiKang XianLin GuLou Hospital, allowing elderly residents to access medical services without leaving the community [2]. - The community offers 24/7 medical services, with 70% to 80% of chronic disease consultations and initial pain treatments provided on-site, minimizing the need for external medical visits [2]. - A case study highlights the effectiveness of this integration, where a rapid response to a medical emergency resulted in a successful treatment within 20 minutes, showcasing the advantages of "zero-distance" collaboration between the community and hospital [3]. Group 2: Health Wealth Planners (HWP) - The emergence of Health Wealth Planners (HWP) represents a new elite workforce aimed at enhancing health management services, with over 22,000 professionals trained under this initiative by the end of 2024 [4]. - The HWP program integrates health management with financial planning, providing comprehensive solutions that address the diverse needs of the aging population [4]. - The training includes specialized education in medical knowledge and real-world healthcare processes, enabling HWPs to assist clients effectively in navigating healthcare services [6]. Group 3: Comprehensive Healthcare Ecosystem - TaiKang's strategy includes the establishment of a multi-layered healthcare ecosystem that integrates community and hospital services, aiming for seamless healthcare delivery [7]. - The company has invested 50 billion yuan in healthcare infrastructure, establishing a network of 280 facilities across 56 cities, which includes the first "medical education research and elderly care" integrated complex in Nanjing [8]. - The focus on elderly medicine as a strategic priority reflects the growing importance of healthcare resources in enhancing the quality of elderly care services [7].

Core Viewpoint - Han Commercial Group (600774.SH) reported a revenue of 1.175 billion yuan for 2024, a decrease of 15.41% year-on-year, primarily due to market fluctuations and policy adjustments in the medical sector [1] Group 1: Financial Performance - The company experienced a revenue decline attributed to the medical sector's income reduction caused by market environment changes and policy adjustments [1] - The company anticipates a recovery in performance by 2025 as it deepens its "Big Health + Big Business" dual main business strategy [1] Group 2: Pharmaceutical Sector - Han Commercial Group has expanded its presence in the big health sector, focusing on chemical drugs, traditional Chinese medicine, and medical devices through its subsidiary, Dikon Pharmaceutical [2] - The company invested over 50 million yuan in R&D for 2024, emphasizing innovation and product development [1] - The company holds complete intellectual property rights for its global Class I innovative drug DDCI-01, which has completed Phase II clinical trials and is entering Phase III for indications related to pulmonary arterial hypertension and benign prostatic hyperplasia [1] Group 3: Traditional Chinese Medicine - The company is progressing with the resumption of production for Dikon Traditional Chinese Medicine following the bankruptcy restructuring of Dongfang Pharmaceutical, achieving the market launch of 13 products [2] - The star product, Tongqiao Bi Yan Granules, sold over 13 million boxes in 2024, marking a 20% increase year-on-year [2] Group 4: Medical Devices - Dikon Zhongke, a subsidiary, has seen growth in its absorbable medical devices, including absorbable bone fixation screws and membranes, with successful bids in various provinces [2] - The company is advancing the development of new medical devices, obtaining multiple registration certificates and inspection approvals [2] Group 5: Assisted Reproductive Technology - The company plans to enhance support for key disciplines in assisted reproduction, aiming to establish a well-known specialty hospital in the field [2] Group 6: Commercial Exhibition Sector - The company is adapting its shopping centers and business operations to market changes, exploring new business models such as low-altitude logistics [3] - The transformation of the former Wuhan wedding photo material city into the Han Chao Z6 project aims to attract a younger demographic [3] - The Wuhan International Exhibition Center is undergoing operational upgrades to create a new service model for the exhibition industry [3] Group 7: Future Strategy - The company aims to strengthen its pharmaceutical sector by focusing on traditional Chinese medicine, enhancing sales, and driving R&D [3] - The commercial sector will focus on precise positioning and upgrading to enhance profitability and invigorate traditional brands [3]

Group 1: Event Overview - The "Jiangsu·Nanjing Taiwan Week" features over 20 activities across various fields, with participation from more than 1,000 individuals including Taiwanese business groups and youth representatives [2] - The event's theme is "Ning Good Taiwan, Together Towards the Future," highlighting cultural exchanges and cooperation opportunities between Taiwan and Nanjing [2] Group 2: Cultural Exchange - A campus folk song carnival at the opening ceremony evoked shared memories among guests, with classic songs leading to a collective sing-along [3] - Discussions on "Literary Dialogue in the Digital Age" took place between writers and publishers from both sides, exploring historical and contemporary literary connections [3] - Performances showcased traditional and modern cultural expressions, emphasizing the shared cultural roots between the two regions [3] Group 3: Culinary Collaboration - A cross-strait food market featured 40 stalls offering a variety of Taiwanese and Nanjing delicacies, attracting significant public interest [4] - Taiwanese food stalls included popular items such as oyster omelets and bubble tea, with participation from local entrepreneurs and teams exploring culinary culture [4][5] Group 4: Business Opportunities - The food market's success led to plans for a long-term collaboration to establish a "Ning-Tai Cultural and Culinary Exchange Practice Base" [5] - Over 50% of the participating vendors were young entrepreneurs, indicating a growing interest among Taiwanese youth in exploring business opportunities in Nanjing [5] Group 5: Industrial Cooperation - A special event focused on the electrical and mechanical industry featured Taiwanese representatives discussing new cooperation opportunities [6] - Notable Taiwanese enterprises have established a presence in Nanjing, with nearly 4,000 approved Taiwanese projects and over 1,000 operational Taiwanese companies as of December 2024 [6] Group 6: Historical and Cultural Significance - Activities included the unveiling of the Sun Yat-sen Academic Research Center and an exhibition on the Treaty of Shimonoseki, reflecting the historical ties between Taiwan and Nanjing [6] - Participants engaged in various cultural experiences, deepening their understanding of traditional Chinese culture and modern development achievements [6]

Core Viewpoint - The company has announced a retrospective adjustment of financial data due to the acquisition of a 92.3333% stake in Anhui Xiangtai Automotive Chassis Components Co., Ltd, which is considered a business combination under common control [6][7][9]. Financial Data - The financial statements for the first quarter of 2025 have not been audited [1]. - The net profit of the acquired company before the merger was -6,168,774.49 yuan, compared to -5,152,759.86 yuan in the previous period [4]. Shareholder Information - There were no changes in the top ten shareholders or significant shareholders due to the transfer of shares [4]. Business Operations - No new retail stores were opened or closed in the first quarter of 2025 [11][12]. - The company plans to open three new "San Feng Qiao Food Specialty Stores" and four "7-11" convenience stores between April and June 2025 [13]. Meeting Resolutions - The seventh meeting of the ninth board of directors and the seventh meeting of the ninth supervisory board were held on April 28, 2025, where the financial report and the retrospective adjustment of financial data were approved [16][24][30].

Market Overview - The stock market experienced significant volatility due to President Trump's latest tariff announcements, with investors awaiting potential agreements between the U.S. and trade partners [1] - Major indices rebounded after an initial decline, with the S&P 500 rising over 4%, the Nasdaq Composite increasing nearly 7%, and the Dow Jones Industrial Average gaining over 2% [1] Company Performance - VeriSign's stock rose 8% on Friday, reaching a new intraday high, following a strong first-quarter revenue report and the announcement of a cash dividend of $0.77 per share [4] - Netflix's stock also reached a new intraday high, increasing over 13% for the week, driven by a 13% growth in first-quarter revenue attributed to strong subscription and advertising income [5] Stock Analysis - VeriSign is identified as one of the overbought stocks with an RSI of 70.45, indicating potential short-term pullback risks despite a target price suggesting over 7% downside [2] - Netflix's average target price is approximately $1,116, indicating only about 1% upside potential from the recent closing price [6] - Bristol-Myers Squibb and UnitedHealth Group are noted as oversold stocks, with RSIs of 24.41 and 28.87 respectively, and both companies have underperformed the market [7] - Bristol-Myers Squibb's stock has dropped over 21.5% in April, while UnitedHealth's has decreased by 20.1% year-to-date [10] Future Outlook - Bristol-Myers Squibb has raised its full-year revenue and earnings guidance, while UnitedHealth has lowered its full-year performance outlook due to rising medical costs [9] - Market consensus target prices suggest over 17% upside potential for Bristol-Myers Squibb and over 36% for UnitedHealth [10]